ÂÜÀòÂÒÂ×

Dr. Manu Sehgal has extensive experience in the pharmaceutical industry, having held various leadership positions in reputable companies. From 2020 to the present, they have served as Vice President at CONTINUUM India LLP, leading consulting projects in regulatory intelligence, evidence submissions, and reimbursement submissions.

Prior to this, Dr. Sehgal worked as Vice President at Course5i in 2019 and at Parexel from 2013 to 2018. At Parexel, they were responsible for evidence evaluation and served as the head of India Operations for PAREXEL ACCESS Consulting. Dr. Manu successfully led health outcomes and analytics projects, sold and delivered key consulting projects, and led over 100 evidence evaluation engagements for pharmaceutical clients in Europe and the US.

Before joining Parexel, Dr. Sehgal held senior-level positions at HERON - A PAREXEL COMPANY and HERON Health. Dr. Manu also gained experience at Basic Healthcare Products, Quantum Solutions India, Dabur Research Foundation, Panacea Biotec Ltd, and Morepen Laboratories Limited India earlier in their career. Overall, Dr. Sehgal's work experience spans a wide range of roles and responsibilities within the pharmaceutical and healthcare industry.

Dr. Manu Sehgal holds a M. Pharm degree in Pharmacy/Clinical Pharmacology and Therapeutics from the Birla Institute of Technology and Science, Pilani, which they obtained in 2002. In addition, they have obtained several additional certifications throughout their career, including Commercialization and Innovation from the Massachusetts Institute of Technology (MIT) in 2015, PRINCE2 in 2012, and Good Clinical Practice and GCP from the Academy of Clinical Excellence in 2004 and 2002, respectively.